Cargando…

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)

INTRODUCTION: The ‘Study of Intravenous Autologous Marrow in Multiple Sclerosis (SIAMMS)’ trial was a safety and feasibility study which examined the effect of intravenous infusion of autologous bone marrow without myeloablative therapy. This trial was well tolerated and improvement was noted in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Claire M, Marks, David I, Walsh, Peter, Kane, Nick M, Guttridge, Martin G, Redondo, Juliana, Sarkar, Pamela, Owen, Denise, Wilkins, Alastair, Scolding, Neil J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567673/ https://www.ncbi.nlm.nih.gov/pubmed/26363342 http://dx.doi.org/10.1136/bmjopen-2015-009090

Ejemplares similares

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
por: Rice, Claire M., et al.
Publicado: (2015)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
por: Redondo, Juliana, et al.
Publicado: (2017)

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum
por: Redondo, Juliana, et al.
Publicado: (2014)

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
por: Sarkar, Pamela, et al.
Publicado: (2018)

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis
por: Redondo, Juliana, et al.
Publicado: (2018)

Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
por: Kemp, Kevin C., et al.
Publicado: (2018)

Reductions in kinesin expression are associated with nitric oxide-induced axonal damage
por: Redondo, Juliana, et al.
Publicado: (2015)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2022)

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2016)

Erratum to: ‘Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia’
por: Kemp, Kevin C., et al.
Publicado: (2016)

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells
por: Kemp, Kevin C., et al.
Publicado: (2018)

Cell fusion in the brain: two cells forward, one cell back
por: Kemp, Kevin, et al.
Publicado: (2014)

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015)

Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment
por: Witherick, Jonathan, et al.
Publicado: (2010)

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Stem Cells in Subacute Ischemic Stroke Patients
por: Ghali, Azza Abass, et al.
Publicado: (2016)

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
por: King, A, et al.
Publicado: (2015)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
por: Gray, Elizabeth, et al.
Publicado: (2012)

Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells
por: Kemp, Kevin, et al.
Publicado: (2017)

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
por: Sarkar, Pamela, et al.
Publicado: (2021)

Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
por: Liu, Baochi, et al.
Publicado: (2021)

Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia
por: Nguyen, Thanh Liem, et al.
Publicado: (2022)

The Fate and Distribution of Autologous Bone Marrow Mesenchymal Stem Cells with Intra-Arterial Infusion in Osteonecrosis of the Femoral Head in Dogs
por: Jin, Hongting, et al.
Publicado: (2016)

Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023)

Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts
por: Kemp, Kevin, et al.
Publicado: (2011)

Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model
por: Kemp, Kevin C., et al.
Publicado: (2017)

Intravenous and hepatic arterial infusion of high dose mitomycin C with autologous bone marrow transplantation in patients with tumour metastatic to the liver.
por: Corringham, R. E., et al.
Publicado: (1984)

Bringing back the help: autologous bone marrow infusion restores CD4(+) T cells in AIDS patients with chronic liver disease
por: Rabson, A B
Publicado: (2013)

Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis
por: Hristov, M, et al.
Publicado: (2006)

Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy
por: Sengupta, Upal, et al.
Publicado: (2013)

Percutaneous Endoscopic Gastrostomy Tube Insertion in Neurodegenerative Disease: A Retrospective Study and Literature Review
por: Sarkar, Pamela, et al.
Publicado: (2017)

Autologous bone marrow transplantation in patients relapsed one year after R-CHOP?
por: Pereira, Juliana
Publicado: (2012)

Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
por: Zhang, Weiwei, et al.
Publicado: (2018)

Autologous Infusion of Bone Marrow and Mesenchymal Stromal Cells in Patients with Chronic Obstructive Pulmonary Disease: Phase I Randomized Clinical Trial
por: Squassoni, Selma Denis, et al.
Publicado: (2021)

Comparison and characterization of enriched mesenchymal stem cells obtained by the repeated filtration of autologous bone marrow through porous biomaterials
por: Chu, Wenxiang, et al.
Publicado: (2019)

A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI)
por: Hamshere, Stephen, et al.
Publicado: (2014)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia
por: Abuljadayel, Ilham Saleh, et al.
Publicado: (2006)

Neurosarcoidosis: a clinical approach to diagnosis and management
por: Ibitoye, Richard T., et al.
Publicado: (2016)

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)

Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
por: Baumert, Bartłomiej, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hbk2mvejs9qp1vetqbnicijvet